Teva UK seeks government’s assurance to reduce pressure on pharmacies due to energy crisis


Share post:

Teva UK has alerted the Secretary of State for Health and Social Care to the problem posed by steep energy prices.

Teva’s UK General Manager Kim Innes wrote to the minister seeking assurances that the distribution of medicines to patients will be safeguarded over what’s likely to be a difficult winter.

The problems posed by steep energy prices and the potential for power rationing is putting pharmacies under pressure from increased costs and the risk of losing power supplies as a ‘non-domestic’ energy user, said the company.

Kim said: “In our letter to the Secretary of State we acknowledged that the government knows that medicines manufacture is strategically important and that it’s a vital component in maintaining patient health.”

“But I wanted to make sure that the Secretary of State also realizes the consequences of the energy crisis further down the supply chain – for example, the need for a pharmacy to have a fridge switched on at all times for storing cold chain products.”

“Wholesalers need climate control and lighting 24 hours a day and they can’t decide to simply use less power to reduce bills. The same applies for pharmacies – medicines must be stored within temperature limits, and pharmacies who are already challenged from so many different directions can’t choose to use less energy, and they certainly can’t tolerate simply having electricity cuts, as some of the National Grid’s emergency planning has implied in a worst-case situation.”

Teva says that at the time of writing, the company has not yet received a reply from the Minister’s office.



Please enter your comment!
Please enter your name here

Current Issue June 2023

Related articles

MHRA grants authorisation for LEO Pharma’s Adtralza 2 mL pen solution

The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the marketing authorisation of Adtralza, a dermatological solution...

Grundon launches maiden UK-wide inhaler recycling programme

Grundon Waste Management has introduced what it claims to be the UK's first verified nationwide inhaler return and...

‘Record fine imposed on hydrocortisone manufacturers for dominant position abuse and 10,000% price increase’

The Competition Appeal Tribunal (CAT) has upheld the Competition and Markets Authority’s (CMA) findings against two pharmaceutical manufacturers...

Vision Report: Legal reforms, adequate funding imperative for success of community pharmacy

Achieving the community pharmacy vision necessitates legal adjustments and additional funding beyond recent boosts, the pharmacy vision document...